HomeThemesTypesDBAbout
Showing: ◈ prices×
The increases would come from hefty tariffs on imports and the cost of increased border checks on food coming into the country.
Retail lobby group says higher tariffs and extensive checks would harm consumers.
Retailers reveal ‘mountain of paperwork’ they face – and tell prime minister to strike agreement with EU to minimise damage.
British consumers face higher prices and reduced availability of goods if the government fails to agree pragmatic solutions with the European Union on regulatory checks at ports in any post-Brexit deal, the retail industry’s lobby group warned on Monday.
'This is going to hit us in January....customers are really going to see the problems on supermarket shelves'
'I'm not opposed to tariff cuts, but this article which pretends tariffs are levied on the RETAIL price of a good and that consumers will see a 10% saving at the shops from a 10% tariff cut. / Flatly misleading. Trade illiterate.'
Guy Hands, Terra Firma Capital Partners chairman and chief investment officer, discusses the impact of Brexit on U.K. exports, investment strategy, and the influence of environmental, social and governance issues on the firm's mergers and acquisitions.
President will put US firms first in UK trade talks, says Kim Darroch
Scottish foods that are sold in Europe could be hit by a 50%-plus price hike following Brexit, it has been claimed.
The Chancellor has warned there will be no alignment with EU regulations after Brexit - despite a pledge being made in the North East by Boris Johnson that standards would be protected.
Dire warnings from British industries after Chancellor Sajid Javid admitted businesses will be hit, exposes why the Prime Minister focuses on the trivial.
When President Donald Trump arrived in the United Kingdom this week, he landed bang in the middle of a huge political fight about the country's National Health Service.
Brian Toohey, of the Pharmaceutical Research and Manufacturers of America trade group, spearheads PhRMA and recently told of the US drugs industry's predatory intentions.
This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system
A US-UK trade deal is being negotiated, and drug prices are a key issue. Several US officials are demanding that foreign countries pay higher prices to US drug companies.
Post-Brexit, the cost of medicines they rely on could skyrocket.
Asked if Washington would be free to ‘jack up prices’, Foreign Secretary Dominic Raab replies ‘The Americans will take their decisions’.
How has the Leave vote affected the UK economy, ask Swati Dhingra and Thomas Sampson (LSE) in this second of two blogs based on the CEP Election Analysis briefing on Brexit.
George Hollingbery, then trade minister, and John Saville, Her Majesty’s Consul General in Chicago met a pharmaceutical company's senior director in August last year to discuss a post-Brexit pact.
Labour leader says documents leave Boris Johnson’s denials on post-Brexit US trade deal ‘in tatters’.
Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’.
‘This is clearly an attempt to make it harder for the public and parliament to ensure protections are not traded away’